Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research

Modern systemic therapies for atopic dermatitis : Which factors determine the choice of therapy?
Hautarzt. 2022 Jun 1. doi: 10.1007/s00105-022-05003-7. Online ahead of print.ABSTRACTFor the treatment of moderate to severe atopic dermatitis (AD), two groups of modern systemic therapies with a total of five drugs are currently approved in Germany: biologics (dupilumab, tralokinumab) and "small molecules" (abrocitinib, baricitinib, upadacitinib). The growing armamentarium of therapy options, especially with more than one drug per substance group, makes it challenging for practitioners to select the appropriate treatment for the individual patient. In this review article, the preconditions and requirements of each drug gr...
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Stephan Traidl Annice Heratizadeh Source Type: research

Medical compression stockings for chronic venous diseases and lymphedema : Scientific evidence and results of a patient survey on quality of care
CONCLUSION: MCS are well accepted by patients. When prescribing them, practical aspects such as donning and doffing, recommended wearing time and frequency, and the mechanism of action of MCS should be clearly communicated.PMID:35648140 | DOI:10.1007/s00105-022-05007-3 (Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete)
Source: Der Hautarzt: Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete - June 1, 2022 Category: Dermatology Authors: Markus St ücker Eberhard Rabe Source Type: research